Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia

The COVID-19 pandemic has highlighted the importance of understanding the immune response to seasonal human coronavirus (HCoV) infections such as HCoV-NL63, how existing neutralising antibodies to HCoV may modulate responses to SARS-CoV-2 infection, and the utility of seasonal HCoV as human challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Sean A., Subbarao, Kanta, Mahanty, Siddhartha, Barber, Bridget E., Roulis, Eileen V., van der Hoek, Lia, McCarthy, James S., Spann, Kirsten M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402802/
https://www.ncbi.nlm.nih.gov/pubmed/34452482
http://dx.doi.org/10.3390/v13081618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402802/
https://www.ncbi.nlm.nih.gov/pubmed/34452482
http://dx.doi.org/10.3390/v13081618

Ejemplares similares